Earnings Feed
Start Free
Arno Therapeutics, Inc·4

Jan 28, 4:27 PM ET

Arno Therapeutics, Inc 4

4 · Arno Therapeutics, Inc · Filed Jan 28, 2014

Insider Transaction Report

Form 4
Period: 2014-01-24
Arno Therapeutics, IncARNI
Reizman Yacov
Director
Transactions
  • Award

    Stock Option (right to buy)

    2014-01-24+34,224→ 34,224 total
    Exercise: $2.90Exp: 2024-01-24→ Common Stock (34,224 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2023-11-04→ Common Stock (68,448 underlying)
    68,448

  • 2010 Class B Warrants

    (indirect: By FCC Ltd.)
    Exercise: $3.08From: 2010-09-09Exp: 2015-09-09→ Common Stock (15,750 underlying)
    15,750

  • Common Stock

    (indirect: By FCC Ltd.)
    38,285

  • Stock Option (right to buy)

    Exercise: $8.00Exp: 2020-11-05→ Common Stock (3,750 underlying)
    3,750

  • Warrants (right to buy)

    (indirect: By FCC Ltd.)
    Exercise: $8.80From: 2010-09-09Exp: 2015-09-09→ Common Stock (38,287 underlying)
    38,287
Footnotes (4)
  • [F1]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F2]Vests in three equal annual installments commencing 11/5/11.
  • [F3]Vests in equal 36-monthly installments commencing 12/4/13.
  • [F4]Vests in equal 12-monthly installments commencing 2/24/14.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT